Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells

Neuro-Oncology

Volumn 18, Issue 10, 2016, Pages 1413-1424

  Ledur, Pítia F ^a,c   Liu, Chong ^a,b   He, Hua ^d   Harris, Alexandra R ^a   Minussi, Darlan C ^c   Zhou, Hai Yan ^e   Shaffrey, Mark E ^a   Asthagiri, Ashok ^a   Lopes, Maria Beatriz S ^a   Schiff, David ^a   Lu, Yi Cheng ^d   Mandell, James W ^a   Lenz, Guido ^c   Zong, Hui ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

cell culture; glioma; neural stem cell (NSC); oligodendrocyte precursor cell (OPC); research reproducibility

Indexed keywords

TEMOZOLOMIDE; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG RESPONSE; DRUG SENSITIVITY; GENE EXPRESSION PROFILING; GLIOMA CELL; HUMAN; HUMAN TISSUE; MOUSE; NEURAL STEM CELL; NONHUMAN; OLIGODENDROCYTE PROGENITOR; ANIMAL; CANCER STEM CELL; CELL CULTURE TECHNIQUE; CLUSTER ANALYSIS; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; NERVE CELL; OLIGODENDROGLIA; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR CELL CULTURE; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CLUSTER ANALYSIS; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HETEROGRAFTS; HUMANS; MICE; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; NEURONS; OLIGODENDROGLIA; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TRANSCRIPTOME; TUMOR CELLS, CULTURED;

EID: 84991386960     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/now062     Document Type: Article

References (40)

1. Ocana A, Pandiella A, Siu LL, et al. Preclinical development of molecular-targeted agents for cancer. Nat Rev Clin Oncol. 2011; 8(4):200-209.
2. Freedman LP, Gibson MC, Ethier SP, et al. Reproducibility: changing the policies and culture of cell line authentication. Nat Methods. 2015;12(6):493-497.
3. Boquest AC, Shahdadfar A, Frønsdal K. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell. 2005;16:1131-1141.
4. Maitra A, Arking DE, Shivapurkar N, et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet. 2005;37(10): 1099-1103.
5. Deschavanne PJ, Fertil B. A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys. 1996;34(1):251-266.
6. Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serumcultured cell lines. Cancer Cell. 2006;9(5):391-403.
7. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63(18):5821-5828.
8. Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012;21(3):283-296.
9. Yuan X, Curtin J, Xiong Y, et al. Isolation of cancer stem cells from adult glioblastomamultiforme. Oncogene. 2004;23(58):9392-9400.
10. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med. 2005;353(8):811-822.
11. Reynolds BA, Tetzlaff W, Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci. 1992;12(11):4565-4574.
12. Suvà ML, Rheinbay E, Gillespie SM, et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell. 2014;157(3):580-594.
13. Verhaak RGW, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98-110.
14. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3):157-173.
15. Lindberg N, Kastemar M, Olofsson T, et al. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene. 2009;28(23):2266-2275.
16. Persson AI, Petritsch C, Swartling FJ, et al. Non-stem cell origin for oligodendroglioma. Cancer Cell. 2010;18(6):669-682.
17. Liu C, Sage JC, Miller MR, et al. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell. 2011;146(2):209-221.
18. Assanah M, Lochhead R, Ogden A, et al. Glial progenitors in adult white matter are driven to form malignant gliomas by plateletderived growth factor-expressing retroviruses. J Neurosci. 2006; 26(25):6781-6790.
19. Simon R, Mirlacher M, Sauter G. Tissue microarrays. Biotechniques. 2004;36(1):98-105.
20. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
21. Warnes GR. Gplots: Various R Programming Tools for Plotting Data. 2013. Available at https://cran. r-project. org/web/packages/ gplots/index. html.
22. Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396-1401.
23. Galvao RP, Kasina A, McNeill RS, et al. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process. Proc Natl Acad Sci USA. 2014;111(40):E4214-E4223.
24. Dugas JC, Tai YC, Speed TP, et al. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci. 2006;26(43): 10967-10983.
25. Richardson WD, Pringle N, Mosley MJ, et al. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell. 1988;53(2):309-319.
26. Raff MC, Lillien LE, Richardson WD, et al. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature. 1988;333(6173):562-565.
27. Cahoy JD, Emery B, Kaushal A, et al. A Transcriptome database for astrocytes, eurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci. 2008;28(1):264-278.
28. Obayashi S, Tabunoki H, Kim SU, et al. Gene expression profiling of human neural progenitor cells following the serum-induced astrocyte differentiation. Cell Mol Neurobiol. 2009;29(3):423-438.
29. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors fromhuman glioblastoma. Cancer Res. 2004;64(19):7011-7021.
30. Codega P, Silva-Vargas V, Paul A, et al. Prospective identification and purification of quiescent adult neural stem cells from their in vivo niche. Neuron. 2014;82(3):545-559.
31. Emlet DR, Gupta P, Holgado-Madruga M, et al. Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III. Cancer Res. 2014;74(4):1238-1249.
32. Jiang Y, Boije M, Westermark B, et al. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation. Neoplasia. 2011;13(6):492-503.
33. Ligon KL, Alberta JA, Kho AT, et al. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol. 2004;63(5):499-509.
34. Lindberg N, Jiang Y, Xie Y, et al. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells. J Neurosci. 2014;34(44):14644-14651.
35. Sottoriva A, Spiteri I, Piccirillo SGM, et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA. 2013;110(10):4009-4014.
36. Carro MS, Lim WK, Alvarez MJ, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2010;463(7279):318-325.
37. Ozawa T, Riester M, Cheng Y-K, et al. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell. 2014;26(2):288-300.
38. Bhat KPL, Balasubramaniyan V, Vaillant B, et al. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell. 2013;24(3):331-346.
39. Ligon KL, Huillard E, Mehta S, et al. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron. 2007;53(4): 503-517.
40. Barrett LE, Granot Z, Coker C, et al. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma. Cancer Cell. 2012;21(1):11-24.